Source: Annual Congress 2010 - Nocturnal cardiology: chronic heart failure, acute chest syndrome, coronary artery disease and collagen vascular disease
Disease area: Pulmonary vascular diseases, Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
D. Boisteanu, R. M. Vasiluta, C. E. Mucenica, A. Cernomaz (Iasi, Romania). Long term effects of CPAP therapy in sleep apnea patients with metabolic syndrome. Eur Respir J 2010; 36: Suppl. 54, 911

Member's Comments

No comment yet.

Related content which might interest you: CPAP treatment for sleep apnea syndrome: compliance increases with very long term use Source: Eur Respir J 2005; 26: Suppl. 49, 723s Year: 2005 Effects of long term nCPAP treatment on patients with obstructive sleep apnoea syndrom Source: Eur Respir J 2007; 30: Suppl. 51, 322s Year: 2007 CPAP treatment for obstructive sleep apnoea syndrome after CPAP training term Source: Eur Respir J 2002; 20: Suppl. 38, 102s Year: 2002 CPAP variability in long term follow-up of OSAS (obstructive sleep apnea syndrome) patients Source: Eur Respir J 2006; 28: Suppl. 50, 412s Year: 2006 Glucose-Insulin metabolism in sleep apneoa patients: Effect of long term CPAP treatment Source: Annual Congress 2003 - Systematic inflammation and metabolic disorders in sleep related breathing disorders Year: 2003 The influence of long-term CPAP therapy on metabolic variables in obstructive sleep apnea patients Source: International Congress 2018 – Cardiovascular and metabolic consequences of sleep-disordered breathing Year: 2018 Long-term outcome of nCPAP therapy in sleep apnoea patients Source: Eur Respir J 2004; 24: Suppl. 48, 569s Year: 2004 Possibility of treating patients with obstructive sleep apnea syndrome and nocturnal asystoles using CPAP therapy Source: Annual Congress 2009 - Clinical aspects of sleep apnoea Year: 2009 Pitolisant long term effect in sleepy obstructive sleep apnea patients without CPAP. Source: Virtual Congress 2021 – Advances in therapeutic plans for sleep disordered breathing Year: 2021 Pitolisant long term effect in sleepy obstructive sleep apnea patients with CPAP. Source: Virtual Congress 2021 – Different treatment modalities and impact of comorbidities on sleep disordered breathing Year: 2021 Pitolisant long term effect in sleepy obstructive sleep apnea patients with CPAP Source: Sleep and Breathing Conference 2021 Year: 2021 Pitolisant long term effect in sleepy obstructive sleep apnea patients without CPAP Source: Sleep and Breathing Conference 2021 Year: 2021 Duration of CPAP use in the 1st night of treatment predicts success of therapy in patients with the sleep apnoea syndrome Source: Eur Respir J 2002; 20: Suppl. 38, 100s Year: 2002 Effects of nCPAP treatment on quality of life of patients with obstructive sleep apnoea syndrome Source: Eur Respir J 2006; 28: Suppl. 50, 410s Year: 2006 Indication, compliance and tolerance of CPAP/BiPAP in sleep apnea syndrome in children Source: Annual Congress 2009 - Sleep apnoea across the ages Year: 2009 Effects of CPAP treatment on physical fitness in patients with obstructive sleep apnoea syndrome (OSAS) Source: Eur Respir J 2003; 22: Suppl. 45, 97s Year: 2003 Outcome with CPAP in patients with suspected sleep apnea syndrome Source: Annual Congress 2007 - Sleep apnoea Year: 2007 PAI-uPA system in patients with obstructive sleep apnea syndrome (OSAS) in CPAP treatment Source: Annual Congress 2012 - Cardiovascular disease and sleep-disordered breathing Year: 2012 Night treatment with long acting ß2 agonists in mild COPD patients with sleep apnoea syndrome Source: Eur Respir J 2007; 30: Suppl. 51, 74s Year: 2007 Cardiovascular regulation effects of CPAP therapy in obstructive sleep apnea patients with and without hypertension during daytime Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA II Year: 2012